103 related articles for article (PubMed ID: 5252300)
21. [Trial of treatment of chronic myeloid leukemias with mitomycin C].
Olmer J; Gabriel B
Presse Med (1893); 1971 Oct; 79(44):1965-7. PubMed ID: 5287031
[No Abstract] [Full Text] [Related]
22. [Case of protracted course of myelocytic leukemia].
Korytov SP
Klin Med (Mosk); 1983 Mar; 61(3):102-3. PubMed ID: 6574289
[No Abstract] [Full Text] [Related]
23. [Terminal phase of chronic granulocytic leukemia].
Pawlowski J
Pol Tyg Lek; 1969 Jan; 24(1):14-7. PubMed ID: 5255159
[No Abstract] [Full Text] [Related]
24. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
25. [Hyperlymphocytosis in a case of busulfan-induced medullar aplasia in chronic myeloid leukemia. Chromosome and functional study].
Negrini AC; Azzolini A; Bertocchi I; Dolcino G
Pathologica; 1967; 59(879):407-10. PubMed ID: 5273096
[No Abstract] [Full Text] [Related]
26. [Treatment of chronic myeloid leukemia with dibromomannitol].
Clément F; Saillen R
Schweiz Med Wochenschr; 1970 Nov; 100(46):1995-7. PubMed ID: 5279364
[No Abstract] [Full Text] [Related]
27. [Chronic myeloid leukaemia. Clinical study and analysis of therapeutical results in 55 cases].
Lamas S; Sanjuán I; Zabala P; Millán I; Cabrera R; Barbolla L; Menéndez J; Fernández MN
Sangre (Barc); 1982; 27(4A):493-507. PubMed ID: 6961564
[No Abstract] [Full Text] [Related]
28. [Remarks on the course and prognostic factors in a series of chronic myeloid leukemia].
Furno F; Neretto G; Mazza A; Giovanelli E; Agricola R; Martinetto P
Arch Sci Med (Torino); 1980; 137(3):499-506. PubMed ID: 6940518
[No Abstract] [Full Text] [Related]
29. [Clinico-laboratory data in myelosan therapy of patients with chronic myeloleukoses].
RUSOVA AI
Klin Med (Mosk); 1960 Jul; 38():128-31. PubMed ID: 13744812
[No Abstract] [Full Text] [Related]
30. Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.
Gollerkeri MP; Shah GB
Cancer; 1971 Mar; 27(3):596-601. PubMed ID: 5279330
[No Abstract] [Full Text] [Related]
31. Rotational therapy with a colchicine analog in chronic granulocytic leukemia.
Stolinsky DC; Weiner JM; Bateman JR
Oncology; 1980; 37(1):62-3. PubMed ID: 6927936
[TBL] [Abstract][Full Text] [Related]
32. [Chronic myeloid leukemia with a long survival time].
de Vries SI
Ned Tijdschr Geneeskd; 1969 Jul; 113(28):1225-6. PubMed ID: 5255682
[No Abstract] [Full Text] [Related]
33. [Leukemia planning of chemotherapy].
Kitajima K
Nihon Rinsho; 1975 May; 33(5):1840-6. PubMed ID: 125354
[No Abstract] [Full Text] [Related]
34. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
[No Abstract] [Full Text] [Related]
35. [Amenorrhea in the course of chronic myelotic leukemia treated busulfan].
Chmielewski T; Lemanczyk A
Pol Tyg Lek; 1966 Jan; 21(2):62-3. PubMed ID: 5217377
[No Abstract] [Full Text] [Related]
36. [A study of thrombopoiesis in chronic leucosis in connection with different methods of treatment].
Pogosian AS; Eliian LN; Aĭdinian DS; Bleian GT
Zh Eksp Klin Med; 1969; 9(5):86-90. PubMed ID: 5269261
[No Abstract] [Full Text] [Related]
37. Toxic manifestations of busulfan therapy.
Burns WA; McFarland W; Matthews MJ
Med Ann Dist Columbia; 1971 Sep; 40(9):567-72. PubMed ID: 5315525
[No Abstract] [Full Text] [Related]
38. Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia.
Baker KS; Bostrom B; DeFor T; Ramsay NK; Woods WG; Blazar BR
Bone Marrow Transplant; 2000 Sep; 26(6):607-14. PubMed ID: 11041565
[TBL] [Abstract][Full Text] [Related]
39. [THE USE OF DOPAN AND MYELOSAN IN THE TREATMENT OF PATIENTS WITH CHRONIC MYELOLEUKEMIA].
SPASSKII OV
Sov Med; 1963 May; 26():30-3. PubMed ID: 14073326
[No Abstract] [Full Text] [Related]
40. [Immediate and remote results of treatment of patients with chronic myeloid leukosis with myelosan].
GUREVICH LI
Sov Med; 1960 Oct; 24():84-8. PubMed ID: 13709851
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
